Skip to main content

Table 3 Cox proportional hazard model for PFS

From: Clinical significance of polyglutamylation in primary central nervous system lymphoma

  Univariate analysis Multivariate analysis
Variable HR (95% CI) p HR (95% CI) p
Age 1.015 (0.995–1.036) 0.14 1.005 (0.972–1.038) 0.79
KPS (high vs. low) 1.328 (0.784–2.250) 0.29 0.717 (0.340–1.513) 0.38
Sex (M vs. F) 1.531 (0.953–2.457) 0.078 1.445 (0.820–2.545) 0.20
MSKCC score 1.151 (0.819–1.619) 0.42 0.782 (0.410–1.491) 0.46
Cell of origin (GCB vs. non-GCB) 0.696 (0.407–1.191) 0.19 1.086 (0.576–2.048) 0.80
LDH (high vs. normal range) 1.306 (0.801–2.129) 0.29 1.532 (0.860–2.731) 0.15
Location (deep vs. not deep) 0.928 (0.531–1.622) 0.79 1.377 (0.732–2.587) 0.32
Polyglutamylation vs. non-polyglutamylation 0.439 (0.269–0.716) 0.0010 0.461 (0.259–0.823) 0.0087
  1. PFS progression-free survival, HR hazard ratio, CI confidence interval, KPS Karnofsky performance status, M male, F female